Michael J. Fox attends the Michael J. Fox Foundation for Parkinson's Research gala at Cipriani South Street on Saturday, Oct. 29, 2022, in New York. (Photo by Charles Sykes/Invision/AP)
April 13, 2023 07:39 AM EDTUpdated 11:30 AM
R&D

Up­dat­ed: New da­ta from a mas­sive Parkin­son’s tri­al could lead to break­throughs in drug de­vel­op­ment

Paul Schloesser

Associate Editor

US sci­en­tists af­fil­i­at­ed with the Michael J. Fox Foun­da­tion — named af­ter the Back to the Fu­ture ac­tor di­ag­nosed with Parkin­son’s dis­ease in 1991 — say they …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times